Código QR (código de barras bidimensional)

Outcome of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Progressive Metastatic Neuroendocrine Tumors from a Tertiary Care Center

Introduction: Functioning neuroendocrine tumors (NETs) that do not respond to standard therapies are commonly considered for Peptide Receptor Radionuclide Therapy (PRRT). The benefit of 177Lu-DOTATATE PRRT in patients with progressive metastatic NET was analyzed and survival in multi-organ involveme...

Fuld beskrivelse

Na minha lista:
Principais autores: David Mathew, Saumya S. Sunny, Justin Benjamin, Junita R. John, Felix K. Jebasingh, Josh T. Georgy, Ashish Singh, Regi Oommen
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Medknow Publications 2024-12-01
Serier:Indian Journal of Endocrinology and Metabolism
Fag:
68ga-dotatate
kaplan–meier survival estimates
177lu-dotatate
net
neuroendocrine tumor
peptide receptor radionuclide therapy
prrt
Online adgang:https://journals.lww.com/10.4103/ijem.ijem_372_23
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker